An unknown buyer entered into an agreement to acquire Manufacturing facility in Modiin, Israel and certain related assets from Vascular Biogenics Ltd. (NasdaqGM:VBLT) for $7.1 million on February 15, 2023. The asset sale is subject to customary closing conditions as provided in the purchase agreement and expected to close on or about March 9, 2023.